Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dornier MedTech pioneered extracorporeal shock wave lithotripsy (ESWL), revolutionizing non-invasive treatment for kidney stones. Its ESWL devices are considered a gold standard globally, with millions of patients treated. The company also offers advanced surgical lasers and digital health tools such as UroGPT™, an AI-powered support platform for kidney stone patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dornier MedTech.